Skip to main content
. Author manuscript; available in PMC: 2015 Apr 15.
Published in final edited form as: J Pharm Biomed Anal. 2014 Jan 9;92:63–68. doi: 10.1016/j.jpba.2014.01.001

Table 2.

Accuracy and Precision in Plasma (A) or Plasma Pre-Stabilized with 0.1% HCl (B)

A
Nominal (ng/mL) GM (ng/mL) SD (ng/mL) DEV (%) WRP (%) BRP (%) n
1.0 (LLOQ) 1.10 0.12 10.0011.95 10.5010.29 4.296.61 1820
3.0 (LQC) 2.79 0.26 −7.506.84 6.126.06 7.638.43 2019
200 (MQC) 194.96 12.26 −2.52 2.97 6.24 20
400 (HQC) 374.50 27.67 −6.38 4.82 6.31 20
5,000 (DQC) 4930.44 471.27 −1.39 2.20 10.47 20
B
Nominal (ng/mL) GM (ng/mL) SD (ng/mL) DEV (%) WRP (%) BRP (%) n
1.0 (LLOQ) 1.07 0.10 10.807.33 10.0311.53 −6.82 1820
3.0 (LQC) 2.79 0.25 −6.91–7.83 7.707.93 5.406.92 2019
200 (MQC) 183.14 11.56 −8.43 5.63 3.21 20
400 (HQC) 406.26 60.43 1.56 13.95 5.80 20
5,000 (DQC) 4538.70 407.55 −9.23 5.73 7.78 20

Abbreviations: GM, grand mean; SD, standard deviation; DEV (%) relative deviation from nominal value; WRP, within-run precision; n, number of replicate observations within each validation run; BRP, between-run precision (A hyphen indicates MSwit>MSbet, thus BRP cannot be calculated and it was concluded that no additional variation was observed as a result of performing the assay in different runs)